{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:54:17Z","timestamp":1787504057582,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen (SE)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1266-4","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T07:28:48Z","timestamp":1447054128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988"],"prefix":"10.1186","volume":"15","author":[{"given":"Margr\u00e9t Johansson","family":"Gudj\u00f3nsd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Hentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Backhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Elfvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kawash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Trollfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM200001063420103","volume":"342","author":"SJ Schrag","year":"2000","unstructured":"Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15\u201320.","journal-title":"N Engl J Med"},{"key":"1266_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/599369","volume":"49","author":"TH Skoff","year":"2009","unstructured":"Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990\u20132007. Clin Infect Dis. 2009;49:85\u201392.","journal-title":"Clin Infect Dis"},{"key":"1266_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s15010-007-7251-0","volume":"36","author":"P Sendi","year":"2008","unstructured":"Sendi P, Johansson L, Norrby-Teglund A. Invasive group B streptococcal disease in non-pregnant adults. Infection. 2008;36:100\u201311.","journal-title":"Infection"},{"key":"1266_CR4","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.00117-07","volume":"45","author":"H-C Slotved","year":"2007","unstructured":"Slotved H-C, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiea serotype. J Clin Microbiol. 2007;45:2929\u201336.","journal-title":"J Clin Microbiol"},{"key":"1266_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","volume":"379","author":"KM Edmond","year":"2012","unstructured":"Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379:547\u201356.","journal-title":"Lancet"},{"key":"1266_CR6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/323350","volume":"184","author":"FY Lin","year":"2001","unstructured":"Lin FY, Philips JB, Azimi PH, Weisman LE, Clark P, Rhoads GG, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: a multicenter seroepidemiology study. J Infect Dis. 2001;184:1022\u20138.","journal-title":"J Infect Dis"},{"key":"1266_CR7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10096-008-0565-8","volume":"27","author":"H Bergseng","year":"2008","unstructured":"Bergseng H, Rygg M, Bevanger L, Bergh K. Invasive group B streptococcus (GBS) disease in Norway 1996\u20132006. Eur J Clin Microbiol Infect Dis. 2008;27:1193\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1266_CR8","unstructured":"Jacobsson B, H\u00e5kansson S. Infpreg: Grupp B streptokocker (in Swedish). Available online at: http:\/\/www.medscinet.se\/infpreg\/specinfo\/specinfo.asp (accessed 16 April 2015)."},{"key":"1266_CR9","first-page":"1","volume":"51","author":"S Schrag","year":"2002","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51:1\u201322.","journal-title":"MMWR Recomm Rep"},{"key":"1266_CR10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.inf.0000131633.74921.90","volume":"23","author":"SL Lukacs","year":"2004","unstructured":"Lukacs SL, Schoendorf KC, Schuchat A. Trends in sepsis-related neonatal mortality in the United States, 1985\u20131998. Pediatr Infect Dis J. 2004;23:599\u2013603.","journal-title":"Pediatr Infect Dis J"},{"key":"1266_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1473-3099(03)00577-2","volume":"3","author":"MR Moore","year":"2003","unstructured":"Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prohylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis. 2003;3:201\u201313.","journal-title":"Lancet Infect Dis"},{"key":"1266_CR12","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3201\/eid1410.080185","volume":"14","author":"C Poyart","year":"2008","unstructured":"Poyart C, Reglier-Poupet H, Tazi A, Billo\u00ebt A, Dmytruk N, Bidet P, et al. Invasive group B streptococcal infections in infants. France Emerg Infect Dis. 2008;14:1647\u20139.","journal-title":"France Emerg Infect Dis"},{"key":"1266_CR13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1067\/mob.2001.113875","volume":"184","author":"FY Lin","year":"2001","unstructured":"Lin FY, Brenner RA, Johnson YR, Azimi PH, Phillips JB 3rd, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001;184:1204\u201310.","journal-title":"Am J Obstet Gynecol"},{"key":"1266_CR14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2051013615579869","volume":"3","author":"A Nuticelli","year":"2015","unstructured":"Nuticelli A, Rinaudo CD, Maione D. Group B Streptococcus vaccine: state of the art. Ther Adv Vaccines. 2015;3:76\u201390.","journal-title":"Ther Adv Vaccines"},{"key":"1266_CR15","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1128\/JCM.41.9.4445-4447.2003","volume":"41","author":"HC Slotved","year":"2003","unstructured":"Slotved HC, Elliot J, Thompson T,\u00a0Konradsen HB . Latex assay for serotyping of group B Streptococcus isolates. J Clin Microbiol. 2003;41:4445\u20137.","journal-title":"J Clin Microbiol"},{"key":"1266_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1469-0691.2000.00007.x","volume":"6","author":"S Berg","year":"2000","unstructured":"Berg S, Trollfors B, Lagergard T, Zackrisson G, Claesson BA. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect. 2000;6:9\u201313.","journal-title":"Clin Microbiol Infect"},{"key":"1266_CR17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1469-0691.2004.00931.x","volume":"10","author":"E Persson","year":"2004","unstructured":"Persson E, Berg S, Trollfors B, Larsson P, Ek E, Backhaus E, et al. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998\u20132001. Clin Microbiol Infect. 2004;10:791\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"1266_CR18","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/JCM.03554-13","volume":"52","author":"S Teatero","year":"2014","unstructured":"Teatero S, McGeer A, Low DE, Li A, Demczuk W, Martin I, et al. Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol. 2014;52:1441\u20137.","journal-title":"J Clin Microbiol"},{"key":"1266_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/JCM.21.3.361-362.1985","volume":"21","author":"J Jelinkova","year":"1985","unstructured":"Jelinkova J, Motlova J. Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J Clin Microbiol. 1985;21:361\u20132.","journal-title":"J Clin Microbiol"},{"key":"1266_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/INF.0b013e3182184fe4","volume":"30","author":"GL Oladottir","year":"2011","unstructured":"Oladottir GL, Erlendsdottir H, Palsson G, Bj\u00f6rnsdottir ES, Kristinsson KG, Haraldsson \u00c1. Increasing incidence of late-onset neonatal invasive group B streptococcal infections in Iceland. Pediatr Infec Dis J. 2011;30:661\u20133.","journal-title":"Pediatr Infec Dis J"},{"key":"1266_CR21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/432804","volume":"41","author":"MS Edwards","year":"2005","unstructured":"Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis. 2005;41:839\u201347.","journal-title":"Clin Infect Dis"},{"key":"1266_CR22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/infdis\/jis605","volume":"206","author":"S Bellais","year":"2012","unstructured":"Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, et al. Capsular switching in group B streptococcus CC17 hypervirulent clone: a future challenge for polysachharide vaccine development. J Infect Dis. 2012;206:1745\u201352.","journal-title":"J Infect Dis"},{"key":"1266_CR23","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","volume":"299","author":"CR Phares","year":"2008","unstructured":"Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States 1999\u20132005. JAMA. 2008;299:2056\u201365.","journal-title":"JAMA"},{"key":"1266_CR24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1017\/S0950268813001647","volume":"142","author":"M Morozumi","year":"2014","unstructured":"Morozumi M, Wajima T, Kuwata Y, Chiba N, Sunaoshi K, Sugita K, et al. Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptoccus agalactiae isolates from Japanese infants with invasive infections. Epidemiol Infect. 2014;142:812\u20139.","journal-title":"Epidemiol Infect"},{"key":"1266_CR25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jit481","volume":"209","author":"S Browall","year":"2014","unstructured":"Browall S, Norman M, T\u00e5ngrot J, Galanis I, Sj\u00f6str\u00f6m K, Dagerhamn JW, et al. Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children. J Infect Dis. 2014;209:377\u201388.","journal-title":"J Infect Dis"},{"key":"1266_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/jit145","volume":"208","author":"YC Hsieh","year":"2013","unstructured":"Hsieh YC, Lin TL, Chang KY, Huang YC, Chen CJ, Lin TY, et al. Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as to its ancestral clone, Taiwan19F-14 (ST236). J Infect Dis. 2013;208:203\u201310.","journal-title":"J Infect Dis"},{"key":"1266_CR27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/00365540500532852","volume":"38","author":"S Berg","year":"2006","unstructured":"Berg S, Trollfors B, Persson E, Backhaus E, Larsson P, Ek E, et al. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis. 2006;38:427\u201332.","journal-title":"Scand J Infect Dis"},{"key":"1266_CR28","first-page":"358","volume":"9","author":"HB Konradsen","year":"2002","unstructured":"Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol. 2002;9:358\u201365.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1266_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0950268803001511","volume":"132","author":"MK Pedersen","year":"2004","unstructured":"Pedersen MK, Hoiby EA, Froholm LO, Hasseltvedt V, Lermark G, Caugant DA. Systemic pneumococcal disease in Norway 1995\u20132001: capsular serotypes and antimicrobial resistance. Epidemiol Infect. 2004;132:167\u201375.","journal-title":"Epidemiol Infect"},{"key":"1266_CR30","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/j.vaccine.2014.06.003","volume":"32","author":"G Oster","year":"2014","unstructured":"Oster G, Edelsberg J, Hennegan K, Lewin C, Narasimhan V, Slobod K, et al. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective? Vaccine. 2014;32:4778\u201385.","journal-title":"Vaccine"},{"key":"1266_CR31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","volume":"33","author":"RA Gladstone","year":"2015","unstructured":"Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, et al. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine. 2015;33:2015\u201321.","journal-title":"Vaccine"},{"key":"1266_CR32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/323339","volume":"184","author":"B Henriques Normark","year":"2001","unstructured":"Henriques Normark B, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, et al. Dynamics of penicillinsusceptible clones in invasive pneumococcal disease. J Infect Dis. 2001;184:861\u20139.","journal-title":"J Infect Dis"},{"key":"1266_CR33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4161\/hv.28675","volume":"10","author":"W Phongsamart","year":"2014","unstructured":"Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, et al. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009\u20132012. Hum Vaccin Immunother. 2014;10:866\u201373.","journal-title":"Hum Vaccin Immunother"},{"key":"1266_CR34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1469-0691.2011.03628.x","volume":"17","author":"A Tazi","year":"2011","unstructured":"Tazi A, Morand PC, Reglier-Poupet H, Dmytruk N, Billo\u00ebt A, Antona D, et al. Invasive group B streptococcal infections in adults, France (2007\u20132010). Clin Microbiol Infect. 2011;17:1587\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1266_CR35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10096-010-0941-z","volume":"29","author":"L Lambertsen","year":"2010","unstructured":"Lambertsen L, Ekelund K, Skovsted IC, Liboriussen A, Slotved HC. Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004. Eur J Clin Microbiol Infect Dis. 2010;29:1071\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1266_CR36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10096-014-2055-5","volume":"33","author":"M Meehan","year":"2014","unstructured":"Meehan M, Cunney R, Cafferkey M. Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching. Eur J Clin Microbiol Infect Dis. 2014;33:1155\u201362.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1266_CR37","first-page":"141","volume":"120","author":"A Shet","year":"2004","unstructured":"Shet A, Ferrieri P. Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian J Med Res. 2004;120:141\u201350.","journal-title":"Indian J Med Res"},{"key":"1266_CR38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/JCM.05488-11","volume":"50","author":"ER Martins","year":"2012","unstructured":"Martins ER, Melo-Cristino J, Ramirez M, the Portugese Group for the Study of Streptococcal Infections. Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal. J Clin Microbiol. 2012;50:1219\u201327.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1266-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:06:39Z","timestamp":1599782799000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/15\/507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1266-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]},"article-number":"507"}}